Adipose‑PAS interactions in the context of its localised bio‑engineering potential (Review)
- Authors:
- Michal Nohawica
- Abdelmounaim Errachid
- Marzena Wyganowska‑Swiatkowska
-
Affiliations: Chair and Department of Dental Surgery and Periodontology, Poznan University of Medicinal Sciences, Poznan, Greater Poland 60‑812, Poland - Published online on: July 5, 2021 https://doi.org/10.3892/br.2021.1446
- Article Number: 70
-
Copyright: © Nohawica et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Muneoka K and Dawson LA: Evolution of epimorphosis in mammals. J Exp Zool B Mol Dev Evol. 336:165–179. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Cai S, Fu X and Sheng Z: Dedifferentiation: A new approach in stem cell research. Bioscience. 57:655–662. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Wang C, Liu W, Shen Y, Chen J, Zhu H, Yang X, Jiang X, Wang Y and Zhou J: Cardiomyocyte dedifferentiation and remodeling in 3D scaffolds to generate the cellular diversity of engineering cardiac tissues. Biomater Sci. 7:4636–4650. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Becker RO: Induced dedifferentiation: A possible alternative to embryonic stem cell transplants. NeuroRehabilitation. 17:23–31. 2002.PubMed/NCBI | |
|
Yao Y and Wang C: Dedifferentiation: Inspiration for devising engineering strategies for regenerative medicine. NPJ Regen Med. 5(14)2020.PubMed/NCBI View Article : Google Scholar | |
|
Sugawara A and Sato S: Application of dedifferentiated fat cells for periodontal tissue regeneration. Hum Cell. 27:12–21. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Biehl JK and Russell B: Introduction to stem cell therapy. J Cardiovasc Nurs. 24:98–105. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Jiang M, He B, Zhang Q, Ge H, Zang MH, Han ZH, Liu JP, Li JH, Zhang Q, Li HB, et al: Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: Meta-analysis. Expert Opin Biol Ther. 10:667–680. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Sobhani A, Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S and Sargolzaei Aval F: Multipotent stem cell and current application. Acta Med Iran. 55:6–23. 2017.PubMed/NCBI | |
|
Feyen DAM, Gaetani R, Doevendans PA and Sluijter JPG: Stem cell-based therapy: Improving myocardial cell delivery. Adv Drug Deliv Rev. 106:104–115. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sanchez-Gurmaches J and Guertin DA: Adipocyte lineages: Tracing back the origins of fat. Biochim Biophys Acta. 1842:340–351. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Sebo ZL, Jeffery E, Holtrup B and Rodeheffer MS: A mesodermal fate map for adipose tissue. Development. 145(dev166801)2018.PubMed/NCBI View Article : Google Scholar | |
|
Chamberlain G, Fox J, Ashton B and Middleton J: Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 25:2739–2749. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Hepler C, Shan B, Zhang Q, Henry GH, Shao M, Vishvanath L, Ghaben AL, Mobley AB, Strand D, Hon GC and Gupta RK: Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice. Elife. 7(e39636)2018.PubMed/NCBI View Article : Google Scholar | |
|
Lynes MD and Tseng YH: Deciphering adipose tissue heterogeneity. Ann N Y Acad Sci. 1411:5–20. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ronconi V, Turchi F, Bujalska IJ, Giacchetti G and Boscaro M: Adipose cell-adrenal interactions: Current knowledge and future perspectives. Trends Endocrinol Metab. 19:100–103. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Mullur R, Liu YY and Brent GA: Thyroid hormone regulation of metabolism. Physiol Rev. 94:355–382. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Rippa AL, Kalabusheva EP and Vorotelyak EA: Regeneration of dermis: Scarring and cells involved. Cells. 8(607)2019.PubMed/NCBI View Article : Google Scholar | |
|
Grant RW and Dixit VD: Adipose tissue as an immunological organ. Obesity (Silver Spring). 23:512–518. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kassem M: Mesenchymal stem cells: Biological characteristics and potential clinical applications. Cloning Stem Cells. 6:369–374. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Vojtaššák J, Danišovič Ľ, Kubeš M, Bakoš D, Jarabek L, Uličná M and Blaško M: Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuroendocrinol Lett. 27 (Suppl 2):S134–S137. 2006.PubMed/NCBI | |
|
Smith RKW: Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil. 30:1752–1758. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Zhou W, Han C, Song Y, Yan X, Li D, Chai Z, Feng Z, Dong Y, Li L, Xie X, et al: The performance of bone marrow mesenchymal stem cell-implant complexes prepared by cell sheet engineering techniques. Biomaterials. 31:3212–3221. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Pountos I, Jones E, Tzioupis C, McGonagle D and Giannoudis PV: Growing bone and cartilage. The role of mesenchymal stem cells. J Bone Joint Surg Br. 88:421–426. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Holmes B, Fang X, Zarate A, Keidar M and Zhang LG: Enhanced human bone marrow mesenchymal stem cell chondrogenic differentiation in electrospun constructs with carbon nanomaterials. Carbon. 97:1–13. 2016. | |
|
Gianakos AL, Sun L, Patel JN, Adams DM and Liporace FA: Clinical application of concentrated bone marrow aspirate in orthopaedics: A systematic review. World J Orthop. 8:491–506. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Sakamoto T, Miyazaki T, Watanabe S, Takahashi A, Honjoh K, Nakajima H, Oki H, Kokubo Y and Matsumine A: Intraarticular injection of processed lipoaspirate cells has anti-inflammatory and analgesic effects but does not improve degenerative changes in murine monoiodoacetate-induced osteoarthritis. BMC Musculoskelet Disord. 20(335)2019.PubMed/NCBI View Article : Google Scholar | |
|
Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, Antsaklis A and Anagnou NP: Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: Comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 16:931–952. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Bieback K, Kern S, Kocaömer A, Ferlik K and Bugert P: Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng. 18 (1 Suppl):S71–S76. 2008.PubMed/NCBI | |
|
Francis MP, Sachs PC, Elmore LW and Holt SE: Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction. Organogenesis. 6:11–14. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wouters G, Grossi S, Mesoraca A, Bizzoco D, Mobili L, Cignini P and Giorlandino C: Isolation of amniotic fluid-derived mesenchymal stem cells. J Prenat Med. 1:39–40. 2007.PubMed/NCBI | |
|
Li C, Kilpatrick CD, Smith S, Glettig DL, Glod DJ, Mallette J, Strunk MR, Chang J, Angle SR and Kaplan DL: Assessment of multipotent mesenchymal stromal cells in bone marrow aspirate from human calcaneus. J Foot Ankle Surg. 56:42–46. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Matsumoto T, Kano K, Kondo D, Fukuda N, Iribe Y, Tanaka N, Matsubara Y, Sakuma T, Satomi A, Otaki M, et al: Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential. J Cell Physiol. 215:210–222. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Turner NJ, Jones HS, Davies JE and Canfield AE: Cyclic stretch-induced TGFbeta1/Smad signaling inhibits adipogenesis in umbilical cord progenitor cells. Biochem Biophys Res Commun. 377:1147–1151. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Gustafson B and Smith U: Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem. 285:14031–14041. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Strioga M, Viswanathan S, Darinskas A, Slaby O and Michalek J: Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 21:2724–2752. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Liao Y, Zeng Z, Lu F, Dong Z, Chang Q and Gao J: In vivo dedifferentiation of adult adipose cells. PLoS One. 10(e0125254)2015.PubMed/NCBI View Article : Google Scholar | |
|
Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Hollenberg AN and Flier JS: Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem. 279:36093–36102. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Zhuang H, Zhang X, Zhu C, Tang X, Yu F, Shang GW and Cai X: Molecular mechanisms of PPAR-γ governing MSC osteogenic and adipogenic differentiation. Curr Stem Cell Res Ther. 11:255–264. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Wieser F, Waite L, Depoix C and Taylor RN: PPAR action in human placental development and pregnancy and its complications. PPAR Res. 2008(527048)2008.PubMed/NCBI View Article : Google Scholar | |
|
Yessoufou A and Wahli W: Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly. 140(w13071)2010.PubMed/NCBI View Article : Google Scholar | |
|
Takada I, Kouzmenko AP and Kato S: Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol. 5:442–447. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Otto TC and Lane MD: Adipose development: From stem cell to adipocyte. Crit Rev Biochem Mol Biol. 40:229–242. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Chen L, Song J, Cui J, Hou J, Zheng X, Li C and Liu L: microRNAs regulate adipocyte differentiation. Cell Biol Int. 37:533–546. 2013.PubMed/NCBI View Article : Google Scholar | |
|
McBeath R, Pirone DM, Nelson CM, Bhadriraju K and Chen CS: Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. 6:483–495. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Clabaut A, Delplace S, Chauveau C, Hardouin P and Broux O: Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes. Differentiation. 80:40–45. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wang QA, Song A, Chen W, Schwalie PC, Zhang F, Vishvanath L, Jiang L, Ye R, Shao M, Tao C, et al: Reversible De-differentiation of mature white adipocytes into preadipocyte-like precursors during lactation. Cell Metab. 28:282–288.e3. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kruglikov IL, Zhang Z and Scherer PE: The role of immature and mature adipocytes in hair cycling. Trends Endocrinol Metab. 30:93–105. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Maurizi G, Della Guardia L, Maurizi A and Poloni A: Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol. 233:88–97. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Marangoni RG, Korman BD, Wei J, Wood TA, Graham LV, Whitfield ML, Scherer PE, Tourtellotte WG and Varga J: Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheumatol. 67:1062–1073. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Motrescu ER and Rio MC: Cancer cells, adipocytes and matrix metalloproteinase 11: A vicious tumor progression cycle. Biol Chem. 389:1037–1041. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Plikus MV, Guerrero-Juarez CF, Ito M, Li YR, Dedhia PH, Zheng Y, Shao M, Gay DL, Ramos R, His TC, et al: Regeneration of fat cells from myofibroblasts during wound healing. Science. 355:748–752. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Merrick D and Seale P: Skinny fat cells stimulate wound healing. Cell Stem Cell. 26:801–803. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kurebayashi S, Sumitani S, Kasayama S, Jetten AM and Hirose T: TNF-alpha inhibits 3T3-L1 adipocyte differentiation without downregulating the expression of C/EBPbeta and delta. Endocr J. 48:249–253. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Sartipy P and Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA. 100:7265–7270. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Ruan H and Lodish HF: Insulin resistance in adipose tissue: Direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 14:447–455. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K and Kasuga M: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 116:1494–1505. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Panee J: Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine. 60:1–12. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Furlan F, Orlando S, Laudanna C, Resnati M, Basso V, Blasi F and Mondino A: The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci. 117:2909–2916. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Montuori N and Ragno P: Multiple activities of a multifaceted receptor: Roles of cleaved and soluble uPAR. Front Biosci (Landmark Ed). 14:2494–2503. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Catalán V, Frühbeck G and Gómez-Ambrosi J: Chapter 8-Inflammatory and oxidative stress markers in skeletal muscle of obese subjects. In: Obesity. del Moral AM and Aguilera García CM (eds). Academic Press, pp163-189, 2018. | |
|
Yang D, Wei F, Tewary P, Howard OM and Oppenheim JJ: Alarmin-induced cell migration. Eur J Immunol. 43:1412–1418. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Ren P, Sun D, Xin D, Ma W, Chen P, Gao H, Zhang S and Gong M: Serum amyloid A promotes osteosarcoma invasion via upregulating αvβ3 integrin. Mol Med Rep. 10:3106–3112. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Bernstein AM, Twining SS, Warejcka DJ, Tall E and Masur SK: Urokinase receptor cleavage: A crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell. 18:2716–2727. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M and Blasi F: The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA. 99:1359–1364. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Liu D, Kou X, Chen C, Liu S, Liu Y, Yu W, Yu T, Yang R, Wang R, Zhou Y and Shi S: Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors. Cell Res. 28:918–933. 2018.PubMed/NCBI View Article : Google Scholar | |
|
He W, Tan R, Dai C, Li Y, Wang D, Hao S, Kahn M and Liu Y: Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J Biol Chem. 285:24665–24675. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Akimoto T, Ushida T, Miyaki S, Akaogi H, Tsuchiya K, Yan Z, Williams RS and Tateishi T: Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signaling. Biochem Biophys Res Commun. 329:381–385. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Lee H, Kang R, Bae S and Yoon Y: AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/β-catenin pathway in 3T3-L1 adipocytes. Int J Mol Med. 28:65–71. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Renner G, Noulet F, Mercier MC, Choulier L, Etienne-Selloum N, Gies JP, Lehmann M, Lelong-Rebel I, Martin S and Dontenwill M: Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells. Oncotarget. 7:62194–62207. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB and Ma LJ: Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab. 290:E103–E113. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Swiatkowska M, Szemraj J and Cierniewski CS: Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site. FEBS J. 272:5821–5831. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Kruithof EK: Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost. 100:969–975. 2008.PubMed/NCBI | |
|
Su SC, Lin CW, Yang WE, Fan WL and Yang SF: The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opin Ther Targets. 20:551–566. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Prabhakar NR and Semenza GL: Oxygen sensing and homeostasis. Physiology (Bethesda). 30:340–348. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Darby IA and Hewitson TD: Hypoxia in tissue repair and fibrosis. Cell Tissue Res. 365:553–562. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Fierro FA, O'Neal AJ, Beegle JR, Chávez MN, Peavy TR, Isseroff RR and Egaña JT: Hypoxic pre-conditioning increases the infiltration of endothelial cells into scaffolds for dermal regeneration pre-seeded with mesenchymal stem cells. Front Cell Dev Biol. 3(68)2015.PubMed/NCBI View Article : Google Scholar | |
|
Ye J: Adipose tissue vascularization: Its role in chronic inflammation. Curr Diab Rep. 11:203–210. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Lund IK, Nielsen BS, Almholt K, Rønø B, Hald A, Illemann M, Green KA, Christensen IJ, Rømer J and Lund LR: Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. Dev Biol. 358:56–67. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Carriero MV and Stoppelli MP: The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling. Curr Pharm Des. 17:1944–1961. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010.PubMed/NCBI View Article : Google Scholar | |
|
McCawley LJ and Matrisian LM: Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol Med Today. 6:149–156. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Zhao Y, Lyons CE Jr, Xiao A, Templeton DJ, Sang QA, Brew K and Hussaini IM: Urokinase directly activates matrix metalloproteinases-9: A potential role in glioblastoma invasion. Biochem Biophys Res Commun. 369:1215–1220. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lafont JE: Lack of oxygen in articular cartilage: Consequences for chondrocyte biology. Int J Exp Pathol. 91:99–106. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Shen J, Sugawara A, Yamashita J, Ogura H and Sato S: Dedifferentiated fat cells: An alternative source of adult multipotent cells from the adipose tissues. Int J Oral Sci. 3:117–124. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Hausman GJ and Richardson RL: Adipose tissue angiogenesis. J Anim Sci. 82:925–934. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Lijnen HR: Angiogenesis and obesity. Cardiovasc Res. 78:286–293. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Trayhurn P: Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 93:1–21. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Chabot V, Dromard C, Rico A, Langonné A, Gaillard J, Guilloton F, Casteilla L and Sensebé L: Urokinase-type plasminogen activator receptor interaction with β1 integrin is required for platelet-derived growth factor-AB-induced human mesenchymal stem/stromal cell migration. Stem Cell Res Ther. 6(188)2015.PubMed/NCBI View Article : Google Scholar | |
|
Crandall DL, Busler DE, McHendry-Rinde B, Groeling TM and Kral JG: Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1. J Clin Endocrinol Metab. 85:2609–2614. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Egners A, Erdem M and Cramer T: The response of macrophages and neutrophils to hypoxia in the context of cancer and other inflammatory diseases. Mediators Inflamm. 2016(2053646)2016.PubMed/NCBI View Article : Google Scholar | |
|
Salasznyk RM, Zappala M, Zheng M, Yu L, Wilkins-Port C and McKeown-Longo PJ: The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Matrix Biol. 26:359–370. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Xue Y, Petrovic N, Cao R, Larsson O, Lim S, Chen S, Feldmann HM, Liang Z, Zhu Z, Nedergaard J, et al: Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 9:99–109. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Jośko J and Mazurek M: Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 10:RA89–RA98. 2004.PubMed/NCBI | |
|
Weis SM and Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 437:497–504. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Vandoorne K, Addadi Y and Neeman M: Visualizing vascular permeability and lymphatic drainage using labeled serum albumin. Angiogenesis. 13:75–85. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Kobayashi J, Yamada S and Kawasaki H: Distribution of vitronectin in plasma and liver tissue: Relationship to chronic liver disease. Hepatology. 20:1412–1417. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Goerges AL and Nugent MA: pH regulates vascular endothelial growth factor binding to fibronectin: A mechanism for control of extracellular matrix storage and release. J Biol Chem. 279:2307–2315. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Hapke S, Kessler H, Arroyo de Prada N, Benge A, Schmitt M, Lengyel E and Reuning U: Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. J Biol Chem. 276:26340–26348. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Chu Y, Bucci JC and Peterson CB: Identification of a PAI-1-binding site within an intrinsically disordered region of vitronectin. Protein Sci. 29:494–508. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Arroyo De Prada N, Schroeck F, Sinner EK, Muehlenweg B, Twellmeyer J, Sperl S, Wilhelm OG, Schmitt M and Magdolen V: Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin. Eur J Biochem. 269:184–192. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Wang L, Ly CM, Ko CY, Meyers EE, Lawrence DA and Bernstein AM: uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin. Invest Ophthalmol Vis Sci. 53:4765–4775. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Czekay RP, Aertgeerts K, Curriden SA and Loskutoff DJ: Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol. 160:781–791. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Mousa SA: Vitronectin receptors in vascular disorders. Curr Opin Investig Drugs. 3:1191–1195. 2002.PubMed/NCBI | |
|
Seiffert D, Iruela-Arispe ML, Sage EH and Loskutoff DJ: Distribution of vitronectin mRNA during murine development. Dev Dyn. 203:71–79. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Aaboe M, Offersen BV, Christensen A and Andreasen PA: Vitronectin in human breast carcinomas. Biochim Biophys Acta. 1638:72–82. 2003.PubMed/NCBI View Article : Google Scholar | |
|
van Aken BE, Seiffert D, Thinnes T and Loskutoff DJ: Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochem Cell Biol. 107:313–320. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Shi F and Sottile J: Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J Cell Sci. 121:2360–2371. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lenselink EA: Role of fibronectin in normal wound healing. Int Wound J. 12:313–316. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ricard-Blum S: The collagen family. Cold Spring Harb Perspect Biol. 3(a004978)2011.PubMed/NCBI View Article : Google Scholar | |
|
Scherer PE and Hill JA: Obesity, diabetes, and cardiovascular diseases: A compendium. Circ Res. 118:1703–1705. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhang X, Zhang Y, Wang P, Zhang SY, Dong Y, Zeng G, Yan Y, Sun L, Wu Q, Liu H, et al: Adipocyte hypoxia-inducible factor 2α suppresses atherosclerosis by promoting adipose ceramide catabolism. Cell Metab. 30:937–951.e5. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kaneko M, Minematsu T, Yoshida M, Nishijima Y, Noguchi H, Ohta Y, Nakagami G, Mori T and Sanada H: Compression-induced HIF-1 enhances thrombosis and PAI-1 expression in mouse skin. Wound Repair Regen. 23:657–663. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Samad F, Schneiderman J and Loskutoff D: Expression of fibrinolytic genes in tissues from human atherosclerotic aneurysms and from obese mice. Ann N Y Acad Sci. 811:350–360. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Qureshi R, Kindo M, Arora H, Boulberdaa M, Steenman M and Nebigil CG: Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21+ fibroblast progenitor cell transformation into adipocytes and vascular cells. Sci Rep. 7(12804)2017.PubMed/NCBI View Article : Google Scholar | |
|
Li JQ, Zhao SP, Li QZ, Cai YC, Wu LR, Fang Y and Li P: Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. Clin Chim Acta. 370:57–62. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Geis T, Döring C, Popp R, Grossmann N, Fleming I, Hansmann ML, Dehne N and Brüne B: HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma. Exp Cell Res. 331:46–57. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ekmekci H, Sonmez H, Ekmekci OB, Ozturk Z, Domanic N and Kokoglu E: Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. J Thromb Thrombolysis. 14:221–225. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Reuning U, Magdolen V, Hapke S and Schmitt M: Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol Chem. 384:1119–1131. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Chiellini C, Cochet O, Negroni L, Samson M, Poggi M, Ailhaud G, Alessi MC, Dani C and Amri EZ: Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation. BMC Mol Biol. 9(26)2008.PubMed/NCBI View Article : Google Scholar | |
|
Ekström M, Liska J, Eriksson P, Sverremark-Ekström E and Tornvall P: Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue. Thromb Haemost. 108:485–492. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Lijnen HR, Maquoi E, Demeulemeester D, Van Hoef B and Collen D: Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thromb Haemost. 88:345–353. 2002.PubMed/NCBI | |
|
Efimenko A, Starostina E, Kalinina N and Stolzing A: Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med. 9(10)2011.PubMed/NCBI View Article : Google Scholar | |
|
Zhou A, Huntington JA, Pannu NS, Carrell RW and Read RJ: How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol. 10:541–544. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Fukui N, Ikeda Y, Tanaka N, Wake M, Yamaguchi T, Mitomi H, Ishida S, Furukawa H, Hamada Y, Miyamoto Y, et al: αvβ5 Integrin promotes dedifferentiation of monolayer-cultured articular chondrocytes. Arthritis Rheum. 63:1938–1949. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Goessler UR, Bieback K, Bugert P, Heller T, Sadick H, Hörmann K and Riedel F: In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cells and chondrocytes upon dedifferentiation in cell culture. Int J Mol Med. 17:301–307. 2006.PubMed/NCBI | |
|
Clemmons DR, Maile LA, Ling Y, Yarber J and Busby WH: Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress. Growth Horm IGF Res. 17:265–270. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Czekay RP, Kuemmel TA, Orlando RA and Farquhar MG: Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol Biol Cell. 12:1467–1479. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Binder BR, Mihaly J and Prager GW: uPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's view. Thromb Haemost. 97:336–342. 2007.PubMed/NCBI | |
|
Cortese K, Sahores M, Madsen CD, Tacchetti C and Blasi F: Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One. 3(e3730)2008.PubMed/NCBI View Article : Google Scholar | |
|
Rabiej VK, Pflanzner T, Wagner T, Goetze K, Storck SE, Eble JA, Weggen S, Mueller-Klieser W and Pietrzik CU: Low density lipoprotein receptor-related protein 1 mediated endocytosis of β1-integrin influences cell adhesion and cell migration. Exp Cell Res. 340:102–115. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Crampton SP, Wu B, Park EJ, Kim JH, Solomon C, Waterman ML and Hughes CC: Integration of the beta-catenin-dependent Wnt pathway with integrin signaling through the adaptor molecule Grb2. PLoS One. 4(e7841)2009.PubMed/NCBI View Article : Google Scholar | |
|
Dejaeger M, Böhm AM, Dirckx N, Devriese J, Nefyodova E, Cardoen R, St-Arnaud R, Tournoy J, Luyten FP and Maes C: Integrin-linked kinase regulates bone formation by controlling cytoskeletal organization and modulating BMP and Wnt signaling in osteoprogenitors. J Bone Miner Res. 32:2087–2102. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zucker MM, Wujak L, Gungl A, Didiasova M, Kosanovic D, Petrovic A, Klepetko W, Schermuly RT, Kwapiszewska G, Schaefer L and Wygrecka M: LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension. Biochim Biophys Acta Mol Basis Dis. 1865:1604–1616. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Koraishy FM, Silva C, Mason S, Wu D and Cantley LG: Hepatocyte growth factor (Hgf) stimulates low density lipoprotein receptor-related protein (Lrp) 5/6 phosphorylation and promotes canonical Wnt signaling. J Biol Chem. 289:14341–14350. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Masson O, Chavey C, Dray C, Meulle A, Daviaud D, Quilliot D, Muller C, Valet P and Liaudet-Coopman E: LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue. PLoS One. 4(e7422)2009.PubMed/NCBI View Article : Google Scholar | |
|
Jiang F, Parsons CJ and Stefanovic B: Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol. 45:401–409. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Ding X, Tong Y, Jin S, Chen Z, Li T, Billiar TR, Pitt BR, Li Q and Zhang LM: Mechanical ventilation enhances extrapulmonary sepsis-induced lung injury: Role of WISP1-αvβ5 integrin pathway in TLR4-mediated inflammation and injury. Crit Care. 22(302)2018.PubMed/NCBI View Article : Google Scholar | |
|
Stephens S, Palmer J, Konstantinova I, Pearce A, Jarai G and Day E: A functional analysis of Wnt inducible signalling pathway protein-1 (WISP-1/CCN4). J Cell Commun Signal. 9:63–72. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ono M, Inkson CA, Kilts TM and Young MF: WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res. 26:193–208. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Xu J and Liao K: Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem. 279:35914–35922. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Gondi CS, Kandhukuri N, Dinh DH, Gujrati M and Rao JS: Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway. Int J Oncol. 31:19–27. 2007.PubMed/NCBI | |
|
Whitley BR, Beaulieu LM, Carter JC and Church FC: Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Gynecol Oncol. 104:470–479. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Karbiener M, Neuhold C, Opriessnig P, Prokesch A, Bogner-Strauss JG and Scheideler M: MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2. RNA Biol. 8:850–860. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg RJ and Li X: miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci USA. 105:2889–2894. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Ailhaud G, Dani C, Amri EZ and Scheideler M: microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun. 390:247–251. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim MM, Srikantan S, Martindale JL, Hutchison ER, Kim HH, Marasa BS, et al: miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol. 31:626–638. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Kim YJ, Hwang SJ, Bae YC and Jung JS: MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. 27:3093–3102. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, et al: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 279:52361–52365. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Hadadeh O, Barruet E, Peiretti F, Verdier M, Bernot D, Hadjal Y, Yazidi CE, Robaglia-Schlupp A, De Paula AM, Nègre D, et al: The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic stem cells. PLoS One. 7(e49065)2012.PubMed/NCBI View Article : Google Scholar | |
|
Tang CH, Hill ML, Brumwell AN, Chapman HA and Wei Y: Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins. J Cell Sci. 121:3747–3756. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, et al: CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. Oncotarget. 5:12203–12217. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Zhao G, Kim EW, Jiang J, Bhoot C, Charles KR, Baek J, Mohan S, Adams JS, Tetradis S and Lyons KM: CCN1/Cyr61 is required in osteoblasts for responsiveness to the anabolic activity of PTH. J Bone Miner Res. 35:2289–2300. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Asuthkar S, Gondi CS, Nalla AK, Velpula KK, Gorantla B and Rao JS: Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells. J Biol Chem. 287:20576–20589. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, Dinh DH and Rao JS: Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int J Oncol. 28:633–639. 2006.PubMed/NCBI | |
|
Weisel JW: Fibrinogen and fibrin. In: Advances in Protein Chemistry. Vol 70. Academic Press, Cambridge, MA, pp247-299, 2005. | |
|
Neuss S, Schneider RK, Tietze L, Knüchel R and Jahnen-Dechent W: Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs. 191:36–46. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Valenick LV, Hsia HC and Schwarzbauer JE: Fibronectin fragmentation promotes alpha4beta1 integrin-mediated contraction of a fibrin-fibronectin provisional matrix. Exp Cell Res. 309:48–55. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Gavin KM, Majka SM, Kohrt WM, Miller HL, Sullivan TM and Klemm DJ: Hematopoietic-to-mesenchymal transition of adipose tissue macrophages is regulated by integrin β1 and fabricated fibrin matrices. Adipocyte. 6:234–249. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Rodríguez Fernández JL and Ben-Ze'ev A: Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: Inhibition by extracellular matrix and polylysine. Differentiation. 42:65–74. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Liu LF, Shen WJ, Zhang ZH, Wang LJ and Kraemer FB: Adipocytes decrease Runx2 expression in osteoblastic cells: Roles of PPARγ and adiponectin. J Cell Physiol. 225:837–845. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Kortlever RM and Bernards R: Senescence, wound healing and cancer: The PAI-1 connection. Cell Cycle. 5:2697–2703. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Pan Y, Xie C and Zhang Y: miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis. Cell Death Dis. 9(777)2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang Z, Xing H, Hu H, Dai T, Wang Y, Li Z, An R, Xu H, Liu Y and Liu B: Intraglandular transplantation of adipose-derived stem cells combined with platelet-rich fibrin extract for the treatment of irradiation-induced salivary gland damage. Exp Ther Med. 15:795–805. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Gurewich V: Therapeutic fibrinolysis: How efficacy and safety can be improved. J Am Coll Cardiol. 68:2099–2106. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Cao GQ, Li L, Wang YB, Shi ZZ, Fan DY and Chen HY: Treatment of free-flowing tuberculous pleurisy with intrapleural urokinase. Int J Tuberc Lung Dis. 19:1395–1400. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Berkenpas MB, Lawrence DA and Ginsburg D: Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J. 14:2969–2977. 1995.PubMed/NCBI | |
|
Naderi N, Griffin MF, Mosahebi A, Butler PE and Seifalian AM: Adipose derived stem cells and platelet rich plasma improve the tissue integration and angiogenesis of biodegradable scaffolds for soft tissue regeneration. Mol Biol Rep. 47:2005–2013. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rahman SU, Park CH, Baek JH, Ryoo HM and Woo KM: Fibrin-enhanced canonical Wnt signaling directs plasminogen expression in cementoblasts. Int J Mol Sci. 18(2380)2017.PubMed/NCBI View Article : Google Scholar | |
|
Tara S and Krishnan LK: Differentiation of circulating neural progenitor cells in vitro on fibrin-based composite-matrix involves Wnt-β-catenin-like signaling. J Cell Commun Signal. 13:27–38. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhou C, Li S, Wenqiguli N, Yu L, Zhao L, Wu P and Nijiati T: The expressions of the Notch and Wnt signaling pathways and their significance in the repair process of alveolar bone defects in rabbits with bone marrow stem cells compounded with platelet-rich fibrin. Hua Xi Kou Qiang Yi Xue Za Zhi. 34:130–135. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese). |
